NCT00110747 - S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Non-Ablative Facial Laser Resurfacing in Adults | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

September 30, 2005

Study Completion Date

September 30, 2005

Conditions

Pain

Interventions

DRUG

S-Caine™ Peel (lidocaine and tetracaine topical cream 7%/7%)

S-Caine Peel comprising a 1:1 eutectic mixture of 7% lidocaine and 7% tetracaine was applied topically. A thin layer of the peel (approximately 1 mm in thickness) was applied and remained on the treatment area for 30 minutes (±2 minutes).

DRUG

Placebo Peel

Peel was applied topically. A thin layer of the peel (approximately 1 mm in thickness) was applied and remained on the treatment area for 30 minutes (±2 minutes).

Trial Locations (3)

10016

Laser and Skin Surgery Center of New York, New York

10021

New York Dermatology, New York

48038

Midwest Cutaneous Research, Clinton Township

All Listed Sponsors

lead

ZARS Pharma Inc.

INDUSTRY